Calidi Biotherapeutics (CLDI) Institutional Ownership $2.19 +0.18 (+8.96%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Calidi Biotherapeutics (NYSE:CLDI)CurrentInstitutional OwnershipPercentage12.53%Number ofInstitutional Buyers(last 12 months)7Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$659.08K Get CLDI Insider Trade Alerts Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLDI Institutional Buying and Selling by Quarter Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] Calidi Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Red Wave Investments LLC46,461$53K0.0%-92.6%0.418% 8/15/2024Delta Investment Management LLC210,230$42K0.0%+1,955.0%0.413% 8/8/2024 RS Crum Inc.263,470$53K0.0%+2,327.4%0.517% 7/19/2024 CPR Investments Inc.560,000$112K0.1%+700.0%11.002% 5/16/2024 Apollo Management Holdings L.P.125,000$71K0.0%N/A0.352% 5/15/2024 Magnetar Financial LLC63,132$36K0.0%N/A0.178% 5/14/2024 Evermay Wealth Management LLC63,416$36K0.0%N/A0.178% 4/23/2024 Spectrum Asset Management Inc. NB CA 166,494$94K0.0%N/A0.468% (Data available from 1/1/2016 forward) CLDI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLDI shares? During the previous two years, the following institutional investors and hedge funds held shares of Calidi Biotherapeutics shares: CPR Investments Inc. ($112K), Spectrum Asset Management Inc. NB CA ($94K), Apollo Management Holdings L.P. ($71K), Red Wave Investments LLC ($53K), RS Crum Inc. ($53K), Delta Investment Management LLC ($42K), and Magnetar Financial LLC ($36K).Learn more on CLDI's institutional investors. What percentage of Calidi Biotherapeutics stock is owned by institutional investors? 12.53% of Calidi Biotherapeutics stock is owned by institutional investors. Learn more on CLDI's institutional investor holdings. Which institutional investors have been buying Calidi Biotherapeutics stock? The following institutional investors have purchased Calidi Biotherapeutics stock in the last 24 months: CPR Investments Inc. ($490K), RS Crum Inc. ($252.62K), Delta Investment Management LLC ($200K), Spectrum Asset Management Inc. NB CA ($166.49K), Apollo Management Holdings L.P. ($125K), Evermay Wealth Management LLC ($63.42K), and Magnetar Financial LLC ($63.13K). How much institutional buying is happening at Calidi Biotherapeutics? Institutional investors have bought a total of 1,360,658 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Calidi Biotherapeutics major shareholders have been selling company stock? The following institutional investors have sold Calidi Biotherapeutics stock in the last 24 months: Red Wave Investments LLC ($578.14K). How much institutional selling is happening at Calidi Biotherapeutics? Institutional investors have sold a total of 578,141 shares in the last 24 months. This volume of shares sold represents approximately $659.08K in transactions. Related Companies PowerUp Acquisition Institutional Ownership MediciNova Institutional Ownership Genenta Science Institutional Ownership Coherus BioSciences Institutional Ownership I-Mab Institutional Ownership Werewolf Therapeutics Institutional Ownership PDS Biotechnology Institutional Ownership PMV Pharmaceuticals Institutional Ownership BioAtla Institutional Ownership Ikena Oncology Institutional Ownership This page (NYSE:CLDI) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calidi Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLDI Stock Alerts